A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
NCT02485964
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
OTHER:
Blood draw
Sponsor
University of Arkansas